Vineet Laboratories Limited has announced details of its upcoming Rights Issue, approved by the Rights Issue Committee of the Board of Directors on December 17, 2025. The company plans to issue 99,87,258 fully paid-up Equity Shares of face value ₹10 each, at a price of ₹30 per share, including a premium of ₹20. This rights issue aims to raise an aggregate amount of ₹29,96,17,740, assuming full subscription. The Rights Issue will be offered at a ratio of 13 Rights Equity Shares for every 12 Equity Shares held by eligible shareholders as of the record date. The record date for determining entitlement to the rights has been set for December 23, 2025. The Rights Issue period is scheduled to open on January 1, 2026. The last date for on-market renunciation is January 16, 2026, and for off-market renunciation is January 20, 2026. The Rights Issue is expected to close on January 21, 2026, although the company reserves the right to extend the issue period by up to 30 days. Prior to the rights issue, the company has 92,19,008 equity shares outstanding. Upon full subscription, the total outstanding equity shares are expected to increase to 1,92,06,266. The Rights Issue Committee meeting commenced at 2:00 PM and concluded at 3:00 PM on December 17, 2025. The Letter of Offer will be filed with the BSE, NSE, and SEBI, and dispatched to eligible shareholders in due course.